{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:41:14Z","timestamp":1789724474103,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of the University and Research of Italy"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ejpb.2017.04.011","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T21:02:18Z","timestamp":1492030938000},"page":"285-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro \/ in vivo behavior"],"prefix":"10.1016","volume":"115","author":[{"given":"Elisabetta","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Cortesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Drechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingmei M.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Calderan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Nastruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2017.04.011_b0005","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2017.04.011_b0010","first-page":"1","article-title":"Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009\u20132014)","volume":"8","author":"Papini","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejpb.2017.04.011_b0015","doi-asserted-by":"publisher","unstructured":"A.P. Robinson, C.T. Harp, A. Noronha, S.D. Miller, The experimental autoimmune encephalomyelitis (EAE) model of MS. Utility for understanding disease pathophysiology and treatment, in: Multiple Sclerosis and Related Disorders, Handbook of Clinical Neurology, vol. 122, 2014, pp. 173\u20131891.","DOI":"10.1016\/B978-0-444-52001-2.00008-X"},{"key":"10.1016\/j.ejpb.2017.04.011_b0020","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.clim.2011.02.017","article-title":"Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of action","volume":"142","author":"Gold","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejpb.2017.04.011_b0025","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1756285614564152","article-title":"Dimethyl fumarate in the treatment of relapsing\u2013remitting multiple sclerosis: an overview","volume":"8","author":"Bomprezzi","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.ejpb.2017.04.011_b0030","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1007\/s00415-013-6968-1","article-title":"Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study","volume":"260","author":"Hutchinson","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejpb.2017.04.011_b0035","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11910-013-0394-8","article-title":"Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness and side effects","volume":"13","author":"Linker","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ejpb.2017.04.011_b0040","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1007\/s10072-008-1045-8","article-title":"Management of dysphagia in patients affected by multiple sclerosis: state of the art","volume":"29","author":"Giusti","year":"2008","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejpb.2017.04.011_b0045","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejpb.2008.09.003","article-title":"Lipid nanoparticles for parenteral delivery of actives","volume":"71","author":"Joshi","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.04.011_b0050","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1517\/17425247.2012.673278","article-title":"Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery","volume":"9","author":"Battaglia","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2017.04.011_b0055","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.2174\/0929867321666140716095644","article-title":"Nanomedicine based nanoparticles for neurological disorders","volume":"21","author":"Sriramoju","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2017.04.011_b0060","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s11095-013-1122-4","article-title":"Targeted delivery of nano-therapeutics for major disorders of the central nervous system","volume":"30","author":"Gao","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.04.011_b0065","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1602\/neurorx.2.1.108","article-title":"Drug transport to brain with targeted nanoparticles","volume":"2","author":"Olivier","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejpb.2017.04.011_b0070","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2017.04.011_b0075","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jneuroim.2013.02.013","article-title":"Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis","volume":"258","author":"Duchi","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejpb.2017.04.011_b0080","doi-asserted-by":"publisher","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejpb.2017.04.011_b0085","first-page":"445","article-title":"Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles","volume":"6","author":"Tian","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2017.04.011_b0090","first-page":"289","article-title":"Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives","volume":"2","author":"Uner","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2017.04.011_b0095","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood\u2013brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ejpb.2017.04.011_b0100","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijpharm.2007.06.023","article-title":"Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro","volume":"344","author":"Jallouli","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.04.011_b0105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2157-7439.1000256","article-title":"Physico-chemical characterization and biodistribution studies of lipid nanoparticles","volume":"6","author":"Esposito","year":"2015","journal-title":"J. Nanomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2017.04.011_b0110","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejpb.2016.03.005","article-title":"Encapsulation of cannabinoid drugs in nanostructured lipid carriers","volume":"102","author":"Esposito","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.04.011_b0115","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejpb.2011.10.015","article-title":"Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study","volume":"80","author":"Esposito","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.04.011_b0120","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1010067107182","article-title":"Dynamic light scattering measurement of nanometer particles in liquids","volume":"2","author":"Pecora","year":"2000","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.ejpb.2017.04.011_b0125","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejpb.2013.12.011","article-title":"Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin","volume":"86","author":"Esposito","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.04.011_b0130","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/157341113804486400","article-title":"Analysis of the drug release profiles from formulations based on micro and nano systems","volume":"9","author":"Esposito","year":"2013","journal-title":"Curr. Anal. Chem."},{"key":"10.1016\/j.ejpb.2017.04.011_b0135","doi-asserted-by":"publisher","first-page":"6","DOI":"10.14227\/DT190212P6","article-title":"In vitro release testing of PLGA microspheres with Franz diffusion cells","volume":"5","author":"Herrera","year":"2012","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.ejpb.2017.04.011_b0140","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1016\/j.msec.2013.08.017","article-title":"Curcumin containing monoolein aqueous dispersions: a preformulative study","volume":"33","author":"Esposito","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2017.04.011_b0145","first-page":"110","article-title":"Analysis of Fickian and non-Fickian drug release from polymers","volume":"60","author":"Peppas","year":"1985","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.ejpb.2017.04.011_b0150","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ijpharm.2008.09.004","article-title":"Mathematical modeling of drug delivery","volume":"364","author":"Siepmann","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.04.011_b0155","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s10439-011-0321-6","article-title":"Integrin b4 signaling promotes mammary tumor cell adhesion to brain microvascular endothelium by inducing ErbB2-mediated secretion of VEGF","volume":"39","author":"Fan","year":"2011","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.ejpb.2017.04.011_b0160","article-title":"Quantification of malignant breast cancer cell MDA-MB-231 trans-migration across brain and lung microvascular endothelium","author":"Fan","year":"2015","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.ejpb.2017.04.011_b0165","unstructured":"USP34-NF29 General Notices, General notices and requirements, Applying to Standards, Tests, Assays, and Other Specifications of the United States Pharmacopeia, 2011, pp. 1\u201314."},{"key":"10.1016\/j.ejpb.2017.04.011_b0170","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.ejpb.2017.04.011_b0175","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10611860500071292","article-title":"Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns","volume":"13","author":"G\u00f6ppert","year":"2005","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ejpb.2017.04.011_b0180","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4137\/DTI.S12519","article-title":"P-glycoprotein inhibition for optimal drug delivery","volume":"7","author":"Amin","year":"2013","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.ejpb.2017.04.011_b0185","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/10611860500411043","article-title":"Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats","volume":"13","author":"Ambruosi","year":"2005","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ejpb.2017.04.011_b0190","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1748-1716.1985.tb07746.x","article-title":"Endothelial negative surface charge areas and blood\u2013brain barrier function","volume":"125","author":"Hardebo","year":"1985","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejpb.2017.04.011_b0195","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00005072-198703000-00003","article-title":"Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro","volume":"46","author":"Hart","year":"1987","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejpb.2017.04.011_b0200","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/35.11.3655325","article-title":"Demonstration of anionic sites on the luminal and abluminal fronts of endothelial cells with poly-L-lysine-gold complex","volume":"35","author":"Vorbrodt","year":"1987","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ejpb.2017.04.011_b0205","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-3565(24)35204-8","article-title":"Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood\u2013brain barrier","volume":"291","author":"Fenart","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2017.04.011_b0210","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0009-2509(00)00458-9","article-title":"Crystallization behaviour of fats and lipids: a review","volume":"56","author":"Sato","year":"2001","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ejpb.2017.04.011_b0215","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.msec.2014.12.012","article-title":"Cannabinoid antagonist in nanostructured lipid carriers (NLC): design, characterization and in vivo study","volume":"48","author":"Esposito","year":"2015","journal-title":"Matet. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2017.04.011_b0220","doi-asserted-by":"publisher","first-page":"0210021","DOI":"10.1115\/1.4003309","article-title":"An electrodiffusion model for the blood-brain barrier permeability to charged molecules","volume":"133","author":"Li","year":"2011","journal-title":"J. Biomech. Eng."},{"key":"10.1016\/j.ejpb.2017.04.011_b0225","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s10439-010-9920-x","article-title":"Effect of surface charge of immortalized mouse cerebral endothelial cell monolayer on transport of charged solutes","volume":"38","author":"Yuan","year":"2010","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.ejpb.2017.04.011_b0230","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejpb.2014.12.006","article-title":"Biodistribution of nanostructured lipid carriers: a tomographic study","volume":"89","author":"Esposito","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.04.011_b0235","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2217\/nnm.11.79","article-title":"In vivo biodistribution of nanoparticles","volume":"6","author":"Almeida","year":"2011","journal-title":"Nanomedicine"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117304587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117304587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:10:12Z","timestamp":1750198212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117304587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":47,"alternative-id":["S0939641117304587"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.04.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro\/in vivo behavior","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}